Loading...
Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma
BACKGROUND: The monoclonal antibody zolbetuximab (formerly IMAB362), which is being developed as a potential treatment for gastric cancer (GC), targets Claudin 18.2 (CLDN18.2), a GC biomarker. This study aimed to determine the prevalence of CLDN18.2 in primary tumors and lymph node (LN) metastases o...
Na minha lista:
| Udgivet i: | Jpn J Clin Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6792344/ https://ncbi.nlm.nih.gov/pubmed/31087075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyz068 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|